Upgrade to SI Premium - Free Trial

Cowen Cuts Price Target on Solazyme (SZYM) Following Earnings Results

July 31, 2015 7:56 AM
Cowen maintained a Market Perform rating on Solazyme (NASDAQ: SZYM), and cut the price target to $3.25 (from $4.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles